Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders.

Panagiotis Mallis Efstathios MichalopoulosCatherine Stavropoulos-Giokas

Published in: International journal of molecular sciences (2024)

Advanced Therapy Medicinal Products (ATMPs) comprise a heterogenous class of innovative medicinal products, which further require extensive preclinical and clinical assessments before their broader use in the general population [...].

Keyphrases

coronavirus disease
sars cov
cell therapy
stem cells
mesenchymal stem cells